Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice.

Hae-Ran Park | Eun-Jin Ju | Sung-Kee Jo | Uhee Jung | Sung-Ho Kim | Sung-Tae Yee
BMC cancer | 2009

Although cisplatin is one of the most effective chemotherapeutic agents, cisplatin alone does not achieve a satisfactory therapeutic outcome. Also cisplatin accumulation shows toxicity to normal tissues. In this study, we examined the possibility of HemoHIM both to enhance anticancer effect with cisplatin and to reduce the side effects of cisplatin in melanoma-bearing mice.

Pubmed ID: 19292900

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


YAC-1 (tool)

RRID:CVCL_2244

Cell line YAC-1 is a Cancer cell line with a species of origin Mus musculus

View all literature mentions

C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

B16-F0 (tool)

RRID:CVCL_0604

Cell line B16-F0 is a Cancer cell line with a species of origin Mus musculus (Mouse)

View all literature mentions